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A B S T R A C T
Theobjectiveof this studywas to evaluate theefﬁciency and theeffects of changes inparameters of chronic
amygdala–hippocampal deep brain stimulation (AH-DBS) in mesial temporal lobe epilepsy (TLE).
Eight pharmacoresistant patients, not candidates for ablative surgery, received chronic AH-DBS
(130 Hz, follow-up 12–24 months): two patients with hippocampal sclerosis (HS) and six patients with
non-lesional mesial TLE (NLES). The effects of stepwise increases in intensity (0-Off to 2 V) and
stimulation conﬁguration (quadripolar and bipolar), on seizure frequency and neuropsychological
performance were studied.
The two HS patients obtained a signiﬁcant decrease (65–75%) in seizure frequency with high voltage
bipolar DBS (1 V) or with quadripolar stimulation. Two out of six NLES patients became seizure-free,
one of them without stimulation, suggesting a microlesional effect. Two NLES patients experienced
reductions of seizure frequency (65–70%), whereas the remaining two showed no signiﬁcant seizure
reduction. Neuropsychological evaluations showed reversible memory impairments in two patients
under strong stimulation only.
AH-DBS showed long-term efﬁciency in most of the TLE patients. It is a valuable treatment option for
patients who suffer from drug resistant epilepsy and who are not candidates for resective surgery. The
effects of changes in the stimulationparameters suggest that a large zone of stimulationwould be required
inHS patients,while a limited zone of stimulation or even amicrolesional effect could be sufﬁcient inNLES
patients, forwhomthe importanceof theproximity of theelectrode to theepileptogenic zone remains tobe
studied. Further studies are required to ascertain these latter observations.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.1. Introduction
Prevalence of epilepsy in the general population is approxi-
mately 0.7%. Most patients with epilepsy respond well to drug
treatment1–3; however, 20–30% of them are refractory to
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doi:10.1016/j.seizure.2011.03.001treatments such as surgical resection or deep brain stimulation
(DBS) should be considered. Temporal lobe epilepsy (TLE) is the
most frequent focal epileptic syndrome and is often associated
with pharmacoresistance. Resection of mesial temporal structures,
either selective or associated with anterior temporal lobectomy,
can lead to seizure freedom in more than 70% of cases.4,5
Unfortunately, up to 30% of TLE are unsuitable for surgery; either
because of the bilateral nature of the disease or because of
concerns for major post-operative verbal memory loss after
removal of the amygdalo-hippocampal complex.6 This is particu-
larly true for patients with non-lesional left TLE.7
In these cases, DBS of the amygdala–hippocampal complex (AH)
has been proposed as a therapeutic alternative. This consists of
continuous or intermittent electrical stimulation, using pulses
which have a deﬁned form, frequency, width, voltage and stimula-
tion conﬁguration. AH-DBS has been reported in twenty-two TLEvier Ltd. All rights reserved.
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Out of these twenty-two patients, ﬁve became seizure free;
ten patients beneﬁted from a seizure reduction frequency of at
least 50%; six patients showed a reduction of less than 50%; one
patient experienced an increase in seizure frequency. In this group,
high frequency stimulations, 130 or 190 Hz, with a pulse width of
90 or 450ms, were applied, either continually or cyclically. From
these studies, it appears that high frequency DBS is efﬁcient in
a signiﬁcant portion of the patient population (15/22; 68%);
however, the effects of stimulation parameters were not addressed.
Here, we present long-term results of eight patients treated with
unilateral chronic AH-DBS as anti-epileptic treatment of TLE, with a
particular emphasis on the inﬂuence of certainDBS parameters such




Eight patients with intractable TLE epilepsy were treated with
unilateral DBS in the mesial temporal structures between June
2002 to April 2008 (ﬁve females and threemales, median age: 31.5
years, range: 25–47; Table 1). All patients underwent a compre-
hensive work-up, in order to determine if they were candidates for
surgery. This included 3T brain MRI with a state-of-the-art
epilepsy protocol, video-EEG telemetry, interictal positron emis-
sion tomography (PET), ictal and interictal single photon emission
computerized tomography (SPECT), as well as neuropsychological
and psychiatric assessments. All patients, except Pt9, also
underwent an intra-arterial amobarbital test with selective
injection into the anterior choroidal artery in order to rule out
major post-operative verbal memory deﬁcit post-operatively.11
Five patients, Pt4–Pt9, underwent additional intracranial invasive
monitoring with stereotactic depth electrodes in both temporal
lobes. Depth electrodes were inserted perpendicularly to the
surface allowing the recording of the amygdala, the anterior and/or
the posterior hippocampus.
The decision to proceed with DBS rather than resective
surgery was based on the following observations: (1) bilateral
epileptogenic zones (EZ) with or without predominance on one
side and (2) concern over possible post-operative worsening of
(verbal) memory. Patient data and results of the preoperative
work-up are shown in Table 1. Due to the fact that most
patients with hippocampal sclerosis beneﬁt from resective
surgery, only two patients with hippocampal sclerosis were
available for the present study. The remaining six patients had
non-lesional TLE as determined by high-resolution MRI. All
patients had baseline MRI scans acquired with a 1.5T (Pts1–5, 8)
or 3T (Pts7, 9) scanner.
In the two patients with hippocampal sclerosis (Pt1—left and
Pt2—right), implantation was performed in the sclerotic hippo-
campus which was also the site of the seizure onset zone. In cases
of non-lesional TLE, the side of the unilateral DBSwas chosen based
on the seizure onset zone determined through an invasive
exploration (Pt5—right; Pt4, Pt7, Pt8 and Pt9—left; non-invasive
exploration in Pt3—right).
All subjects gave their informed consent to participate in the
study, conducted according to the recommended ethical guidelines
of the Declaration of Helsinki, and approved by the local Ethics
Committee of the University Hospitals of Geneva and Lausanne.
2.2. Implantation procedure of DBS electrodes and neurostimulators
A 3D T1-weighted MRI was acquired under stereotactic
conditions (CRW, Radionics1, Burlington, MA, USA). 3D surgicalplanning was performed on the Framelink stereotactic software
(Medtronic, Minneapolis, MN, USA). The trajectory was planned
along the main axis of the hippocampus at the junction between
the hippocampus and the parahippocampal gyrus in order to avoid
the temporal horn of the ventricle and/or choroidal ﬁssure. In the
operating room, the patient was positioned in a semi-sitting
position. A U-shaped skin incision was performed under local
anesthesia in the occipital region precisely determined by the
entry point of the planned trajectory. The skull was openedwith an
8 mm twist-drill. The dura was carefully perforated with
coagulation to avoid signiﬁcant CSF leakage and the electrode
was implanted under lateral ﬂuoroscopic control. The tip of the
DBS electrode was directed in the upward direction so that the
distal contact(s) could be implantedwithin the amygdala, whereas
the more proximal contacts could be placed along the antero-
posterior axis of the hippocampus. External extension was
performed to provide EEG recordings for three or four days before
internalisation. The day following the implantation procedure, a
postoperative 3D T1 weighted MRI was performed. In cases where
the contacts of the electrode were not clearly identiﬁable, due to
the artefacts, a high resolution CT scan was co-registered with the
preoperative 3D T1-weighted MRI to allow precise localisation of
the electrode contacts. Finally, at day three or four post-
implantation, the stimulator was placed in the ipsilateral
subclavicular space under general anesthesia.
The ﬁve ﬁrst patients received the Pisces-Quad, 3487A,
electrode and the Soletra, 7426 stimulator (Medtronic Inc,
Minneapolis, MN, USA). Each contact of the Pisces-Quad electrode
has a cylinder shape (3 mm length, 1.27 mm diameter). The
electrode has four contacts and the distance between contacts is
6 mm. The electrode is 30 mm in total length.
The last three received the Sub Compact Octad, 3876, electrode
and the Restore stimulator (Medtronic Inc, Minneapolis, MN, USA).
Each contact of the Sub Compact Octad electrode has a cylinder
shape (3 mm length, 1.27 mm diameter). The electrode has 8
contacts and the distance between contacts is 1.5 mm. The
electrode is 34.5 mm in total length.
The Soletra and the Restore neurostimulators are voltage source
stimulators and the amplitudes of stimulation are given in volts.
They produce pseudo monophasic charge balanced pulses: a high
amplitude, short duration and cathodic (negative) phase, precedes
a low amplitude, long duration and anodic (positive) phase.12
These neurostimulators are capacitively coupled to prevent
neurotoxic effects due to residual constant DC charge that occurs
with charge unbalanced pulses.13
2.3. Stimulation parameters and follow-up
The patients were stimulated for at least three months with
each of the different parameters set at a given value, i.e., for each
amplitude tested. At the end of each period, the patients were seen
by the neurologist in order to evaluate the effects of the
stimulation. DBS was delivered continuously (no On/Off stimula-
tion cycles of minutes or seconds), in all cases with a frequency of
130 Hz. Pulse width was 0.45 ms.
DBS was applied initially in a quadripolar conﬁguration
systematically for the ﬁrst six patients without consideration of
the intracranial EEG (Pt1–Pt7). In this conﬁguration, the four
contacts were set as cathodes and the case box of the
neurostimulator was set as the anode. In addition to quadripolar
conﬁguration, DBSwas applied in bipolar conﬁguration to evaluate
effects of a small zone of stimulation in all patients. One contact
was set as a cathode and the other one as an anode. The cathode
was set on the contact adjacent to the most epileptogenic site,
determined by the highest amplitude and most frequent interictal
spikes noted when intracranial EEG was performed through the
Table 1
Patients’ characteristics: age at implantation; age at onset of epilepsy; gender; handedness; duration of follow-upwith DBS inmonths; left (L), right (R); hippocampus sclerosis (HS) or normal (N)MRI; seizure types and frequencies
permonth, partial complex seizure (CPS), secondary generalized seizure (SecGS); anti epileptic drugs (AEDs): Topiramate (TPM), Lamotrigine (LTG), Pregabaline (PGB), Clobazam (CLB), Zonisamide (ZNS), Phenytoin (PHT), Valproate
(PHT), Oxcarbazepine (PHT), Phenobarbital (PB), Primidone (PRM), Levetiracetam (LEV), Clonazepam (LEV), Felbamate (LEV); interictal and ictal EEG ﬁndings, hippocampal focus (Hipp), temporal lobe (TL), equivalent (), superior-
posterior (Sup-post), mesial-anterior (Mes-ant); intra-arterial amobarbital test (IAT); psychiatric evaluation, anxiety (A), depression (D); the performance (total number of elements recalled over 5 repetitions) on the Rey Auditory-
Verbal Learning test (verbal memory—VM) and the Rey Visual Design test (visuo-spatial memory—VSM), as well as the verbal (Vspan) and visuo-spatial span (VSspan) are indicated as N for a normal performance (i.e., >5th



































Pt1 37/24 F/R 74 L HS 4.5 CPS
1.5 SecG
LTG L TL L TL Hipp L Verb
mem Def
N/ VM: N (N) NVM:
N (N) Vspan:
N VSspan: N




Pt2 32/3 F/R 50 R HS 17.5 CPS LTG/PHT CLB R TL L TL R TL Hipp R Verb
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Pt7 31/14 M/R 34 N 7 CPS LEV Invasive
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Invasive
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N/N VM: N (N) NVM:
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Pt9 26/13 F/R 10 N bilateral
periventricular
heterotopias
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C. Boe¨x et al. / Seizure 20 (2011) 485–490488implanted electrode, before the internalisation of the neurosti-
mulator. The anode was set on the contact closest to the second
major interictal epileptogenic site. When the neurostimulator was
implanted (Pt7–Pt9) or when it had to be changed because the
battery was discharged (Pt1–Pt4), the subjects were observed for
three months without stimulation, referred to as off-time in this
study.
The numbers of seizures per month were established. The pre-
implantation baselines were determined prospectively as the
mean number of seizures per month averaged over the last three
months before implantation and did not include presurgical
evaluation time. In both HS patients, the increases in seizure rates
were most intense at the time the batteries were discharged, thus
the seizure count of Off periods beganwith a noticeable increase. In
the cases of NLES TLE, changes in seizure rates were not associated
with battery discharges, thus we began the seizure count at the
time the neurostimulator was interrogated and that showed the
batterywas discharged. In all cases, the stimulatorswere turned on
as soon as they were implanted again, usually three months after
the interrogation of the neurostimulator that showed the battery
was discharged.
Major drug changes were avoided after implantation in order to
estimate the effect of DBS. Minor changes of drug dosages were
accepted but introduction of any new antiepileptic drug was not
allowed and one patient, Pt6, was excluded from the study for this
reason.
All patients received a neuropsychological assessment during
follow-up with an emphasis on memory testing in verbal and
visuospatial modalities in view of the implantation sites. Verbal
and visual long and short-termmemory were tested using the Rey
Auditory-Verbal Learning Task (RAVLT), the Rey Visual Design Test
(RVDT), and the Verbal and Visuospatial Supraspan.14,15 For the
RAVLT and the RVDT, two indices were used, namely the sum of
items reproduced during the ﬁve learning sessions, and the
number of items recalled after 40 min after the last learning
session (delayed recall). For the verbal and visuo-spatial spans, the
maximum number of elements correctly reproduced in the direct
orderwas considered as the span. These valueswere referred to the
norms for persons of the same sex, age group and level of
education. Scores falling between the 2nd and 5th percentile were
considered impaired (I), while scores below the 2nd percentile
were deemed severely impaired (SI). Performances above the 5th
percentile were considered normal (N).[()TD$FIG]Fig. 1. Changes in seizure frequencies with DBS parameters compared to the pre-implant
frequency doubled and 0% means the seizure frequency did not change. Means and stan
Results are analyzed for both groups of patients with either LES or NLES TLE. Quadripolar
indicated in volts (0.5–2 V); seizure free patients (*); memory worsening (**).3. Results
3.1. Localisation of the electrode contacts and complications of
surgical procedure
All eight patients were implanted unilaterally with one
electrode in the amygdalo–hippocampal complex as described
in the protocol described above (three on the right side: Pt2, Pt3,
Pt5; ﬁve on the left side: Pt1, Pt4, Pt7, Pt8, Pt9).
No haemorrhagic or infectious complication was observed in
this patient cohort. Displacement of the electrode occurred in Pt5
during the stimulator implantation procedure, necessitating
reimplantation. The contacts assigned to the EZ were located at
the anterior part of the hippocampus (Pt1, Pt7, Pt8), at the
junction of the anterior hippocampus and of the parahippocampal
gyrus (Pt2–Pt4) or at the mid-superior and posterior hippocampus
(Pt9).
Although we did not observe any complication of AH-DBS
resulting from cerebral haemorrhage or infection, one patient
needed to be reimplanted because of an electrode displacement,
resulting from an involuntary traction on the electrode. In another
patient, a fracture of the electrode was identiﬁed just proximal to a
titanium miniplate used for its ﬁxation to the skull. Titanium
miniplates were abandoned in subsequent cases.
3.2. Effects of AH-DBS on seizure frequency
The patients were followed up between 12 and 74 months
(median: 43.5 months).
Fig. 1 describes the changes in complex partial seizure (CPS)
frequencies observed for the different DBS parameters. Changes in
seizure frequencies were compared to the pre-implantation
baseline: 100% means the patient was seizure free; +100%
indicated the seizure frequency doubled and 0% means the
seizure frequency remained unchanged. Means and standard
errors were computed when monthly seizure frequencies could be
calculated.
The two HS patients, Pt1 and Pt2 showed signiﬁcant reductions
in seizure frequencieswith the quadripolar conﬁguration (1 V), i.e.,
67% and 88% respectively (both patients began using these
parameters one year after implantation and subsequently contin-
ued for three years). If a bipolar conﬁguration was used, seizure
reduction was obtained only if at least 1 V was applied (this wasation baseline:100%means the patient was seizure free; +100%means the seizure
dard errors were computed when monthly seizure frequencies could be calculated.
conﬁguration (Quad); stimulation off (Off); amplitudes of bipolar conﬁgurations are
C. Boe¨x et al. / Seizure 20 (2011) 485–490 489only carried out for a few months after several years of
stimulation). However with low amplitude bipolar stimulation
(0.5 V) or during off periods, both patients experienced a
signiﬁcant increase in seizure frequency. For Pt1, secondary
generalized seizures disappeared right after implantation and
ﬁrst stimulation (2 V, quadripolar for the ﬁrst year).
Two out of six NLES patients became seizure free, Pt5 and Pt9.
Pt9 was seizure free two months after the electrode implantation
and without stimulation (the two ﬁnal seizures were observed
during the ﬁrst two months post implantation). No sign of either
macroscopic haemorrhage or microlesion (hypointensity on T1-
weighted images) could be identiﬁed on the postoperative MRIs.
However, the artifact induced by the electrode could have masked
a possible microlesion occurring within 1–3 mm around the
electrode. Pt5 became seizure free with a bipolar conﬁguration
(1 V), but not with the previous quadripolar conﬁguration (he
initially used this quadripolar conﬁguration during six months and
then the bipolar conﬁguration for three years).
In two other patients, Pt3 and Pt4, major seizure reductions of
72 and 84%, respectively, were observed. Pt3 experienced this
reduction with quadripolar conﬁguration (0.5 V, during the ﬁrst
year), and Pt4 with bipolar conﬁguration (0.5 V, one year post
implantation and then for years). Higher bipolar voltages of up to
1.5 or 2 V did not improve seizure occurrence in Pt3 or in Pt4,
respectively (tested over one year). In Pt3, bipolar stimulation
increase to 2.5 V was immediately followed by a typical complex
partial seizure. This effect could be reproduced and conﬁrmedwith
video-EEG monitoring. The DBS parameters were reverted to their
previous values and she returned to her previous seizure
frequency. Pt3 and Pt4 did not experience any signiﬁcant increase
in seizures during an off-period of three months observed at the
time the neurostimulator had to be changed because of battery
discharge (i.e., after three years of DBS).
No signiﬁcant reductions in seizure frequencies were observed
in the remaining two NLES patients, Pt7 and Pt8. Pt7, experienced
his largest decrease in seizure frequencies, 28%, while using
bipolar conﬁguration (1 V, ﬁrst sixmonths). Lower intensity (0.5 V)
or quadripolar conﬁgurations did not improve his condition. Pt8
did not experience any signiﬁcant seizure reduction either during
his initial off period or with bipolar stimulation (1.5 V).
3.3. Neuropsychological evaluation
Verbal and visual memory was tested formally pre- and post-
implantation in ﬁve patients, Pt1, Pt3, Pt4, Pt7 and Pt9. The other
three patients were unwilling to travel to the hospital and declined
post-implantation neuropsychological assessment. Performances
are summarized in Table 1. As noted in Section 2, the performances
on the sum of the 5 trials on the RAVLT and RDVT were considered
normal if they fell above the 5th percentile with respect to the
control population (indicated by the letter N in Table 1).
A performance between 2 and 5th percentile was considered
a moderate impairment (MI) while a score below the 2nd
percentile was a severe impairment (SI). The letters in
parentheses correspond to the performance in the delayed recall
of the task.
In three out of the ﬁve participating patients, Pt1, Pt4 and Pt9,
post-operative verbal memory scores were similar to the pre-
operative ones. In Pt3 however, visual delayed recall became
impaired when the patient was stimulated with 2 V (**bipolar
stimulation, Fig. 1). This was reversed after switching to lower
stimulation amplitudes. For Pt7, both visual and verbal memory
fell below the 5th percentile for immediate and delayed recall
when using the quadripolar stimulation (**quadripolar stimula-
tion, Fig. 1). Visualmemory returnedwithin the normusing bipolar
conﬁguration.When psychiatric assessments could be performed (Hospital
Anxiety and Depression Scale16 and psychiatric interview), no
change was reported (Pt1, Pt3, Pt4, Pt7 and Pt9; Table 1).
4. Discussion
The present long-term study of AH-DBS, with a follow-up of up
to 74 months, showed the variable efﬁciency of AH-DBS hereby
observed in TLE, in accordance with previous studies.8–10 No
irreversible cognitive impairments or psychiatric impairments
were encountered. Thus long-term AH-DBS appears to be a safe
procedure. The analysis of changes in stimulation parameters
suggests that DBS must be tailored individually and that
stimulation parameters should also be taken into account when
considering the efﬁcacy of AH-DBS.
Both HS patients required a strong stimulation (high stimulus
amplitude, at least 1 V, or/andmultipolar conﬁguration) in order to
decrease the seizure frequency. Indeed, when the amplitude of the
bipolar stimulation was lower than 1 V, seizure frequency
increased. Similar observations have been reported by other
authors in this subgroup of patients. One of the two HS patients in
the study of Boon et al.10 became seizure free with high amplitude
stimulation (2–3 V). In addition, they used two contacts as
cathodes and the case box as an anode, i.e., stimulating a large
zone. Velasco et al.9 used bipolar conﬁgurations in their HS
patients at the site of the EZ and small amplitudes of stimulation.
This conﬁguration did not produce a reduction in seizure frequency
in HS patients as that in NLES patients. Tellez-Zenteno et al.8
observed variable effects in four HS patients, ranging from an
increase in seizures to reduction of about 65%, with no seizure free
patient. They used quadripolar conﬁguration and high voltages
between 1.8 and 4 V,which could have produced excitatory effects,
possibly limiting the efﬁciency of DBS. Taken together, these
ﬁndings suggest that a large zone (produced by high amplitude of
stimulation or multipolar conﬁguration), needs to be stimulated in
HS patients in order to obtain a reduction in seizure frequency.
However this should be done by progressing with a stepwise
increase to maximal values at about 2 V.
During off-periods, increases in seizure frequency above pre-
stimulation levels were observed in our study. This was also
reported in two patients studied by Tellez-Zenteno et al.,8 and for
one patient in Velasco et al.9 The seizure increase could be due to a
natural deterioration in the course of the disease, which might be
masked by stimulation.
Four NLES patients beneﬁtted signiﬁcantly from unilateral AH-
DBS. A curative microlesional effect may have occurred in one
patient. Microlesional effects have been reported in few epileptic
patients following diagnostic implantation of depth electrodes in
the temporal lobe17,18 as well as in the ﬁeld of DBS related to
movement disorders.19
A suppression of seizures with a small zone of stimulation (low
amplitude), was observed in one patient. Velasco et al.9 obtained
several seizure free patients with low stimulation amplitudes (low
current in bipolar conﬁguration) after a short period of stimulation
(about twomonths). In two NLES patients, no signiﬁcant difference
inseizure reductionswasobservedbetweenbipolar andquadripolar
conﬁgurations, while applying low amplitudes of stimulation
(maximum of 1 V). Boon et al.10 did not obtain NLES seizure-free
patients with 2 or 3 V stimulation. In one of our cases, habitual
complex partial seizures were even reliably provoked when
intensity was increased up to 2.5 V. Finally, signiﬁcant differences
in seizure reduction were not noted between Off and On periods.
A lack of effect was observed in two NLES patients. In these
cases, the electrode might have been too distant from the primary
EZ. In one case, the non-response may have been due to the fact
that one EZ had been identiﬁed in the superior and posterior part of
C. Boe¨x et al. / Seizure 20 (2011) 485–490490the temporal lobe, in addition to another in themesial structures. It
is possible that the latter may have been involved only as a
secondary EZ. One main parameter could be the electrode distance
from the primary EZ, knowing the EZ can be very limited.20 In NLES
patients, although invasive recordings suggested a participation of
mesial structures, the exact EZmay not have been clearly identiﬁed
in all patients. The efﬁciency of AH-DBS in this subgroup might be
linked to the correlation between the localisation of the EZ and of
the electrode. In some NLES patients the stimulation of the mesial
structures may have produced only a modulation of the neuronal
activity involved in the epileptogenic network with a primary EZ
localised outside the mesial structures.
In thepresent study, all patientswere implantedunilaterally. It is
possible that, in our group of NLES patients presenting bilateral ictal
involvement, bilateral DBS would have produced an improvement.
Indeed, the chances of modulating the neuronal activity involved in
the epileptogenic network may increase remarkably for bilateral
implantations, as reported by Velasco et al.9
Up to now, there are no large studies investigating the cognitive
effects of DBS in patients with epilepsy. Pre-operatively, the
neuropsychological picture in DBS was similar to that observed in
TLE with hippocampal sclerosis or atrophy, showing namely
predominance in memory deﬁcits.21–24 Post-operatively, there was
no signiﬁcant memory decrease in our patients, suggesting that the
insertion of an electrode in the hippocampus does not damage the
structures signiﬁcantly. In twopatients, impairmentswerenotedonly
when stimulation occurred over a large volume (quadripolar
conﬁguration or high intensity). In both cases, the cognitive decline
was completely reversible after returning to previous DBS param-
eters, indicating its functional nature. Closemonitoring of clinicalDBS
effects, with short intervals between neuropsychological evaluations
(e.g., every three or four months), seems mandatory.
In conclusion, AH-DBS appears to be a valuable option for
patients who suffer from pharmacoresistant mesial TLE in whom
ablative surgery is contra-indicated. It is safe and efﬁcient in the
majority of patients. NLES patients are less likely to be operated, in
particular when the focus resides in the language dominant
hemisphere, due to concerns of major verbal memory deﬁcits,
making themmore eligible for DBS. The stimulation parameters of
the AH-DBS must be monitored very carefully, since high
amplitudes of stimulation may be associated with a reversible
worsening of memory function and can even provoke seizures.
Finally, the optimal parameters of stimulation appear to be
different for HS and for NLES patients.
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